Journal profile · Obstetrics & Gynecology
Przeglad Menopauzalny
ISSN 1643-8876 · eISSN 2299-0038 · Termedia Publishing House Ltd. · POLAND · Bimonthly · Founded 2002
Przeglad Menopauzalny: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.2 (journal website); fully open access; APC charged, amount not published; median 68 days to acceptance (50 articles, last 24 months); community-reported acceptance: easy; 37 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Przeglad Menopauzalny is published by Termedia Publishing House Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Endometriosis Research and Treatment, Menopause: Health Impacts and Treatments and Estrogen and related hormone effects, together about 28.6% of its articles. Its main subfields are Obstetrics and Gynecology. (generated from OpenAlex topic counts and CAS ranking data)
Menopause Review/Przegląd Menopauzalny, quarterly, publishes articles on original research (experimental, clinical, laboratory), review papers and case studies of different medical specialties associated with the menopausal period of life. The journal also publishes letters to the Editor, reports and materials from scientific meetings, book reviews, and announcements of planned scientific congresses and conferences. Editors reserve the right to publish editorial commentaries on published works.
From the journal's Aims & Scope
Research area (LetPub): Obstetrics & Gynecology
Editorial board by country: none in mainland China; most named Poland 28, Italy 3, United States 2, Germany 2, United Kingdom 1 (37 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Endometriosis Research and TreatmentMedicine11.1%
- Menopause: Health Impacts and TreatmentsMedicine9.1%
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology8.5%
- Pelvic floor disorders treatmentsMedicine6.7%
- Endometrial and Cervical Cancer TreatmentsMedicine6.4%
- Uterine Myomas and TreatmentsMedicine6.4%
- Ovarian cancer diagnosis and treatmentMedicine6.3%
- Nutrition and Health StudiesMedicine5.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Obstetrics & Gynecology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Obstetrics & Gynecology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 3.8LetPub ·
- SJR 2026-06
- 0.6LetPub ·
- SNIP 2026-06
- 0.89LetPub ·
- h-index
- 12LetPub ·
- h-index
- 40OpenAlex ·
- i10-index
- 203OpenAlex ·
- 2-year mean citedness
- 1.05OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 77LetPub ·
Articles by year OpenAlex count · 1,309 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 17 | 17 | 1 |
| 2025 | 37 | 37 | 38 |
| 2024 | 33 | 33 | 52 |
| 2023 | 42 | 42 | 330 |
| 2022 | 40 | 40 | 423 |
| 2021 | 40 | 40 | 624 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
68 daysMedian, submission to acceptance · P25–P75 43 days – 98 days
- Acceptance to online
- median 82 days (50 articles)
- Submission to online
- median 160 days
- Sample
- 50 articles with submission and acceptance dates (55 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 200 / PLN 1,000 | No | CC BY-NC-SA | |
| LetPub | EUR 100 / PLN 450 | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Peer review, Plagiarism
- Authorship Ghostwriting, guest authorship and plagiarism policy
Przegląd Menopauzalny/Menopause Review has procedures in place to prevent ghostwriting, guest authorship, and plagiarism.
Source ↗Publisher website ·- Conflicts of interest Conflict of interest
Authors are expected to describe sources of the research funding, a role of the potential sponsor in planning, executing and analysis of the study, and the influence (bias) the funding organization had on the content of the article. Other relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) providing potential sources of conflict of interest in relat…
Source ↗Publisher website ·- Peer review Review Process
Integrated with Sarajevo Declaration on Integrity and Visibility of Scholarly Publications Model summary
The registered manuscripts are sent to 2-3 independent experts for scientific evaluation. Submitted papers are accepted for publication after a positive opinion of the independent reviewers. Przegląd Menopauzalny/Menopause Review uses a double-blind review process in which authors do not know the identity of their reviewers, nor do the reviewers know the identities of the authors. The evaluation p…
Source ↗Publisher website ·- Plagiarism Ghostwriting, guest authorship and plagiarism policy
Przegląd Menopauzalny/Menopause Review has procedures in place to prevent ghostwriting, guest authorship, and plagiarism.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Termedia Publishing House Ltd.
- Country or region
- POLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2002
- ISSN
- 1643-8876
- Electronic ISSN
- 2299-0038
- Latest issue on the website
- Volume 25 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Przeglad Menopauzalny
What CAS zone is Przeglad Menopauzalny in?
In the 2025 upgraded edition of the CAS Journal Ranking, Przeglad Menopauzalny is in Zone 4 of Medicine, and in Zone 4 of the minor category Obstetrics & Gynecology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Przeglad Menopauzalny?
The journal's website gives an impact factor of 2.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.8, h-index 40.
How long does peer review take at Przeglad Menopauzalny?
Based on the dates recorded on 50 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 68 days (interquartile range 43–98 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Przeglad Menopauzalny based?
Of the 37 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (28), Italy (3) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Przeglad Menopauzalny?
According to LetPub and DOAJ records, Przeglad Menopauzalny is indexed in Scopus and DOAJ.
Is Przeglad Menopauzalny open access, and what is the APC?
Przeglad Menopauzalny is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .